Innate Pharma S.A. (IPHA) Short Interest
Nasdaq • IPHA • US45781K2042
As of Oct 22, 2026, ORTEX estimated 0.2% of free float sold short, 3.1 days to cover, cost to borrow 5.79%. Sign up for live short interest data.
Nasdaq • IPHA • US45781K2042
As of Oct 22, 2026, ORTEX estimated 0.2% of free float sold short, 3.1 days to cover, cost to borrow 5.79%. Sign up for live short interest data.
This page tracks how heavily Innate Pharma S.A. (Nasdaq:IPHA) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Innate Pharma S.A. (Nasdaq: IPHA) has a market capitalization of $132.07M. Last close $1.44 (as of 2026-11-09); 52-week range $1.17 to $2.71. ORTEX data as of 2026-10-22: short interest was 0.16% of free float, 3.1 days to cover and the average cost to borrow was 5.79%. Sign up for live short interest data.